NewsBenzinga诱饵治疗公司行使1,184,434份第二轮认股权,每股3.25美元,价值约3.85百万美元;将第一轮和第三轮认股权价格调整为3.25美元,并发行2,368,868份新认股权,每股3.25美元 诱饵治疗公司行使1,184,434份第二轮认股权,每股3.25美元,价值约3.85百万美元;将第一轮和第三轮认股权价格调整为3.25美元,并发行2,368,868份新认股权,每股3.25美元 Benzinga 2026.09.22 16:54 (GMT+0) Open on Benzinga Other news Ardent Health Stock Tumbles 14.61% After Hours: Here's Why Lowe's Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts Elon Musk Had a Facepalm Moment After Sean Duffy Defends Rejecting Free Starlink for FAA: ‘Our Airspace Is Very Big’ Abdul El-Sayed Tells Trump He Has Chance to ‘Heal the Sick’: Senator-Elect Says ‘People Really Want Health Care’ Reported Earlier, SPAC Berto To Combine With AMPERA At About $900M Pre-Money Equity Value; Up To $357M Gross Cash Proceeds Expected Iridex (NASDAQ: IRIX) Shares Fall 26.96% After Hours: What Investors Should Know
Lowe's Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Elon Musk Had a Facepalm Moment After Sean Duffy Defends Rejecting Free Starlink for FAA: ‘Our Airspace Is Very Big’
Abdul El-Sayed Tells Trump He Has Chance to ‘Heal the Sick’: Senator-Elect Says ‘People Really Want Health Care’
Reported Earlier, SPAC Berto To Combine With AMPERA At About $900M Pre-Money Equity Value; Up To $357M Gross Cash Proceeds Expected